Growth Metrics

Regeneron Pharmaceuticals (REGN) Property, Plant & Equipment (Net) Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -14.40%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 3.41%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -9.89%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.10%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 10.71%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -0.31%
10 Revolution Medicines 32.39 Bn 32.39 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 10.71%
Dec 31, 2025 10.81%
Sep 30, 2025 10.53%
Jun 30, 2025 9.99%
Mar 31, 2025 9.69%
Dec 31, 2024 9.72%
Sep 30, 2024 9.34%
Jun 30, 2024 8.64%
Mar 31, 2024 9.00%
Dec 31, 2023 8.78%
Sep 30, 2023 8.48%
Jun 30, 2023 8.97%
Mar 31, 2023 9.64%
Dec 31, 2022 9.19%
Sep 30, 2022 10.15%
Jun 30, 2022 10.77%
Mar 31, 2022 10.82%
Dec 31, 2021 10.57%
Sep 30, 2021 10.39%
Jun 30, 2021 10.91%
Mar 31, 2021 10.86%
Dec 31, 2020 10.95%
Sep 30, 2020 11.33%
Jun 30, 2020 10.26%
Mar 31, 2020 8.95%
Dec 31, 2019 11.53%
Sep 30, 2019 13.97%
Jun 30, 2019 14.72%
Mar 31, 2019 16.17%
Dec 31, 2018 17.34%
Sep 30, 2018 19.61%
Jun 30, 2018 22.90%
Mar 31, 2018 29.19%
Dec 31, 2017 34.27%
Sep 30, 2017 40.56%
Jun 30, 2017 47.32%
Mar 31, 2017 55.91%
Dec 31, 2016 58.12%
Sep 30, 2016 60.37%
Jun 30, 2016 61.66%
Mar 31, 2016 61.94%
Dec 31, 2015 61.29%
Sep 30, 2015 58.15%
Jun 30, 2015 52.72%
Mar 31, 2015 44.26%
Dec 31, 2014 38.35%
Sep 30, 2014 31.05%
Jun 30, 2014 25.03%
Mar 31, 2014 18.90%
Dec 31, 2013 14.90%
Sep 30, 2013 12.53%
Jun 30, 2013 12.81%
Dec 31, 2012 13.53%